, respectively. In conclusion, this study found argatroban as a bacterial efflux inhibitor that can be potentially used to overcome efflux-mediated resistance.
No takes yet. Share an insight, caveat, or question.
Behera et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: